Form 4: ClearPoint Neuro Executive Acquires Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
L. Jeremy Stigall, Chief Business Officer of ClearPoint Neuro, Inc., acquired 3,500 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $4.58 per share.
Summary
- On June 28, 2024, L. Jeremy Stigall, Chief Business Officer of ClearPoint Neuro, Inc., acquired 3,500 shares of common stock.
- The acquisition was made through the company's Employee Stock Purchase Plan (ESPP).
- The price per share was $4.58.
- Following the transaction, Stigall beneficially owns 48,692 shares of ClearPoint Neuro, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects a routine transaction under an existing employee stock purchase plan. It's neither overwhelmingly positive nor negative.
Positives
- The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect a significant event impacting the broader neurotech industry.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it shows confidence from a company executive.
Key Dates
| Date | Description |
|---|---|
| January 1, 2024 | Start date of the ESPP purchase period. |
| June 28, 2024 | Date of the transaction (acquisition of shares). |
| June 30, 2024 | End date of the ESPP purchase period. |
| July 2, 2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.